|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2010-4-20
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
A series of 4-(3-biaryl)quinolines with sulfone substituents on the terminal aryl ring (8) was prepared as potential LXR agonists. High affinity LXRbeta ligands with generally modest binding selectivity over LXRalpha and excellent agonist potency in LXR functional assays were identified. Many compounds had LXRbeta binding IC(50) values <10 nM while the most potent had EC(50) values <1.0 nM in an ABCA1 mRNA induction assay in J774 mouse cells with efficacy comparable to T0901317. Sulfone 8a was further evaluated in LDL (-/-) mice and shown to reduce atherosclerotic lesion progression.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1464-3405
|
|
pubmed:author |
pubmed-author:BernotasRonald CRC,
pubmed-author:EnrothChristoferC,
pubmed-author:FeingoldIreneI,
pubmed-author:Goos-NilssonAnnikaA,
pubmed-author:HuseltonChristineC,
pubmed-author:JetterJamesJ,
pubmed-author:MorrisRobertR,
pubmed-author:NambiPonnalP,
pubmed-author:QuinetElaineE,
pubmed-author:TravinsJeremy MJM,
pubmed-author:UllrichJohn WJW,
pubmed-author:UnwallaRayomandR,
pubmed-author:WilhelmssonAnnaA,
pubmed-author:WrobelJayJ
|
|
pubmed:copyrightInfo |
2010 Elsevier Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2903-7
|
|
pubmed:meshHeading |
pubmed-meshheading:20382019-Animals,
pubmed-meshheading:20382019-Atherosclerosis,
pubmed-meshheading:20382019-Binding Sites,
pubmed-meshheading:20382019-Cell Line,
pubmed-meshheading:20382019-Computer Simulation,
pubmed-meshheading:20382019-Humans,
pubmed-meshheading:20382019-Lipoproteins, LDL,
pubmed-meshheading:20382019-Mice,
pubmed-meshheading:20382019-Mice, Knockout,
pubmed-meshheading:20382019-Microsomes,
pubmed-meshheading:20382019-Orphan Nuclear Receptors,
pubmed-meshheading:20382019-Quinolines,
pubmed-meshheading:20382019-Rats,
pubmed-meshheading:20382019-Structure-Activity Relationship,
pubmed-meshheading:20382019-Sulfones
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Synthesis of 4-(3-biaryl)quinoline sulfones as potent liver X receptor agonists.
|
|
pubmed:affiliation |
Chemical Sciences, Wyeth Pharmaceuticals, 500 Arcola Road, Collegeville, PA 19426, USA. JWUllrich@comcast.net
|
|
pubmed:publicationType |
Journal Article
|
